TrialPloS one2014

Evolution of direct costs in the first years of rheumatoid arthritis: impact of early versus late biologic initiation--an economic analysis based on the ESPOIR cohort.

Karine Chevreul et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.